Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Informing Oral Nicotine Pouch Regulations to Promote Public Health
NCT06315881Phase 2Recruiting
- Sponsor
- The Ohio State University Comprehensive Cancer Center – James Cancer Hospital
- Start
- Jan 2025
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of nicotine oral pouch in carcinoma (9 arms), sponsored by The Ohio State University Comprehensive Cancer Center – James Cancer Hospital. Primary endpoints: Increased nicotine delivery up to 3 months, Liking up to 3 months and 2 more. Started Jan 2025; status: recruiting.
02
Drugs
nicotine oral pouch
03
Conditions
carcinoma
Beyond the preview
Go deeper on NCT06315881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06315881.